Dantari Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Employees
-
20
- Latest Deal Type
-
Out of Business
Dantari General Information
Description
Operator of a biotechnology company intended to create medicines for the treatment of cancer and other serious diseases. The company's technology has a significantly higher drug-to-antibody ratio than others and provides further benefits by enabling tunable payload release and delivering much larger payloads for greater efficacy and broad therapeutic potential, enabling healthcare professionals to improve patients' health with a novel antibody-drug conjugate platform.
Contact Information
Website
www.dantari.comCorporate Office
- 1290 Rancho Conejo Boulevard
- Suite 103
- Thousand Oaks, CA 91320
- United States
Corporate Office
- 1290 Rancho Conejo Boulevard
- Suite 103
- Thousand Oaks, CA 91320
- United States
Dantari Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 29-Aug-2024 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 08-Dec-2022 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC | 01-Jan-2019 | Completed | Clinical Trials - Phase 1 |
Dantari Comparisons
Industry
Financing
Details
Dantari Competitors (2)
One of Dantari’s 2 competitors is Erasca, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Erasca | Formerly VC-backed | San Diego, CA | ||||
| Sutro Biopharma | Formerly VC-backed | South San Francisco, CA |
Dantari Patents
Dantari Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025076353-A1 | Cationic polymers and polymer conjugates for delivery of biological agents | Inactive | 05-Oct-2023 | ||
| WO-2025076356-A1 | Poly-nitrophenyl boronic acid-containing polymers | Inactive | 05-Oct-2023 | ||
| WO-2024123732-A1 | Compositions and methods for treatment of prostate cancer | Inactive | 05-Dec-2022 | ||
| AU-2023217093-A1 | Uses and formulations of camptothecin (cpt)-containing nanoparticles | Pending | 14-Feb-2022 | ||
| EP-4479094-A1 | Uses and formulations of camptothecin (cpt)-containing nanoparticles | Pending | 14-Feb-2022 | A61K47/6935 |
Dantari Signals
Dantari FAQs
-
When was Dantari founded?
Dantari was founded in 2018.
-
Where is Dantari headquartered?
Dantari is headquartered in Thousand Oaks, CA.
-
What is the size of Dantari?
Dantari has 20 total employees.
-
What industry is Dantari in?
Dantari’s primary industry is Drug Discovery.
-
Is Dantari a private or public company?
Dantari is a Private company.
-
What is Dantari’s current revenue?
The current revenue for Dantari is .
-
How much funding has Dantari raised over time?
Dantari has raised $47M.
-
Who are Dantari’s competitors?
Erasca and Sutro Biopharma are competitors of Dantari.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process